title: ALK-negative anaplastic lymphoma after autologous stem cell transplant for relapsed diffuse large B-cell lymphoma.
authors.forename: Seah H
authors.initials: SH
authors.lastname: Lim
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Guileyardo
authors.forename: Robbie
authors.initials: R
authors.lastname: Graham
authors.forename: Lorna R
authors.initials: LR
authors.lastname: Strong
authors.forename: William V
authors.initials: WV
authors.lastname: Esler
mesh_terms: D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000628:therapy*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis* / Q000201:enzymology / Q000209:etiology; D008297:Male; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000201:enzymology / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism*; D012008:Recurrence
chemical_list: C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases